| NCT ID | NCT03531918 |
| Title | Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine and Mitoxantrone in Treating Participants With Previously Untreated Acute Myeloid Leukemia or High-Grade Myeloid Neoplasm |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Fred Hutchinson Cancer Research Center |
| Indications | |
| Therapies |
Cladribine + Cytarabine + Filgrastim + Gemtuzumab ozogamicin + Mitoxantrone |
| Age Groups: | adult senior |